74
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Giant Clinically Non-Functioning Pituitary Adenoma Presenting as New Onset Generalized Tonic‒Clonic Seizures: A Case Report

ORCID Icon, ORCID Icon &
Pages 527-533 | Received 08 Mar 2024, Accepted 17 May 2024, Published online: 23 May 2024

References

  • Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO classification of pituitary tumors. Endocrine Pathol. 2022;33(1):6–26. doi:10.1007/s12022-022-09703-7
  • Chen C, Hu Y, Lyu L, et al. Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004–2016. Sci Rep. 2021;11(1):1–9. doi:10.1038/s41598-021-94658-8
  • Vakharia RM, Kremen R, Vakharia A, Adarkwah O, Anderson G. Anterior and posterior suprasellar extensions of a symmetrical trilobed nonfunctional giant pituitary adenoma in the sagittal plane: a case report and review of literature. Radiol Case Rep. 2016;11(4):419–424. doi:10.1016/j.radcr.2016.09.001
  • Iglesias P, Rodríguez Berrocal V, Díez JJ. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches. Endocrine. 2018;61(3):407–421. doi:10.1007/s12020-018-1645-x
  • Han S, Gao W, Jing Z, Wang Y, Wu A. How to deal with giant pituitary adenomas: transsphenoidal or transcranial, simultaneous or two-staged? J Neuro Oncol. 2017;132(2):313–321. doi:10.1007/s11060-017-2371-6
  • Hong CS, Gorrepati R, Kundishora AJ, et al. Case report: suprasellar pituitary adenoma presenting with temporal lobe seizures. Front Surg. 2020;7(December):1–5. doi:10.3389/fsurg.2020.598138
  • Balogun JA, Monsalves E, Juraschka K, et al. Null Cell Adenomas of the Pituitary Gland: an Institutional Review of Their Clinical Imaging and Behavioral Characteristics. Endocrine Pathol. 2015;26(1):63–70. doi:10.1007/s12022-014-9347-2
  • Chentli F, Akkache L, Daffeur K, Azzoug S. General seizures revealing macro-adenomas secreting prolactin or prolactin and growth hormone in men. Indian J Endocrinol Metab. 2014;18(3):361–363. doi:10.4103/2230-8210.131185
  • Papanastasiou L, Fountoulakis S, Pappa T, et al. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene? Hormones. 2014;13(2):290–295. doi:10.1007/bf03401344
  • Aini R, Sachlin IS, Chee LC, Abdullah B. A unilateral nasal mass with generalized seizures: potential diagnostic pitfalls in giant pituitary adenoma. Allergy Rhinol. 2019;10:215265671989658. doi:10.1177/2152656719896580
  • Deepak D, Daousi C, Javadpour M, MacFarlane IA. Macroprolactinomas and epilepsy. Clin Endocrinol. 2007;66(4):503–507. doi:10.1111/j.1365-2265.2007.02759.x
  • Jamaluddin MA, Patel BK, George T, et al. Endoscopic endonasal approach for giant pituitary adenoma occupying the entire third ventricle: surgical results and a review of the literature. World Neurosurg. 2021;154:e254–e263. doi:10.1016/j.wneu.2021.07.022
  • Dhanwal DK, Sharma AK. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma. Pituitary. 2011;14(4):384–387. doi:10.1007/s11102-009-0179-x
  • Koguchi M, Nakahara Y, Ebashi R, et al. Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report. J Med Case Rep. 2019;13(1):18. doi:10.1186/s13256-018-1939-x
  • Plou P, Serioli S, Leonel LCPC, et al. Surgical anatomy and approaches of the anterior cranial fossa from a transcranial and endonasal perspective. Cancers. 2023;15(9):1–13. doi:10.3390/cancers15092587